RFPs
SHARE
SHARE
Resource Downloads
Download RFP
Tambourine is launching the ALS Breakthrough Research Fund. This new fund will support basic and discover-focused research in amyotrophic lateral sclerosis (ALS). The ALS Breakthrough Research Fund is operated in partnership with the Milken Institute Center for Strategic Philanthropy and is now accepting two-year research proposals with the potential to drive significant breakthroughs for improving ALS diagnosis, treatment, management, prevention, and cures.
SHARE
Related Content
-
Request for Proposals: Ann Theodore Foundation Learning Opportunities in Medicine and Sarcoidosis
The ATF-LOMAS is now accepting applications for awards of up to $100,000 per year for two-year research projects led by early career investigators who seek to increase the foundational understanding of sarcoidosis through projects focused...Read Article -
Uterine Leiomyosarcoma: A Giving Smarter Guide
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...Read ReportIM
-
Neuromodulation in Psychiatry: A Giving Smarter Guide
Many of the 1 billion people who live with mental illness do not find meaningful relief, even with evidence-based psychotherapy and medication. A different category of therapy called neuromodulation offers a complementary approach...Read Report
IM
-
Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial
The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...Read Article -
Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment
February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...Read Article -
Milken Institute, Ann Theodore Foundation Announce More Than $2.5 Million in New Funding for Sarcoidosis Research and Launch New Call for Proposals
The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), today announced that the Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF...Read ArticleImage
Sam Roth
Associate Director, Media RelationsSam Roth is the associate director of media relations for the Milken Institute. Based out of the Washington, DC, office, she oversees media coverage for the Health and Strategic Philanthropy pillars. -
The Value of Collaboration in Rare Disease Research
Philanthropy, Collaboration, and Advocacy Overcome Roadblocks at the Intersection of Cancer and Rare Disease Hearing the words “You have cancer” is life-changing—even more so when your cancer is one that doctors very rarely see. This is...Read ArticleImage
Caitlyn Barrett, PhDFormerly Milken Institute -
The Global Brain Care Coalition: A Model to Put Brain Science into Action
It takes an average of 17 years for a scientific discovery to travel from the lab to clinical practice. In brain health, that delay has a real cost as the global population ages and more people face conditions such as dementia, stroke, and...Read Report
